Related references
Note: Only part of the references are listed.The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions
Andre Schmidt et al.
PSYCHOPHARMACOLOGY (2013)
Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin
R. L. Carhart-Harris et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses
Michael P. Bogenschutz et al.
DRUG TESTING AND ANALYSIS (2012)
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
Teri S. Krebs et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Shaping the renaissance of psychedelic research
Ben Sessa
LANCET (2012)
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Robin L. Carhart-Harris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Charles S. Grob et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
Katherine A. MacLean et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
OPINION The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Franz X. Vollenweider et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Treating Drug Abuse and Addiction in the Criminal Justice System Improving Public Health and Safety
Redonna K. Chandler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review
R. Maculaitis et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2008)
Human hallucinogen research: guidelines for safety
M. W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
R. R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Is there a case for MDMA-assisted psychotherapy in the UK? (vol 21, pg 220, 2007)
Ben Sessa
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Is there a case for MDMA-assisted psychotherapy in the UK?
Ben Sessa
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence
Evgeny M. Krupitsky et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2007)
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
R. R. Griffiths et al.
PSYCHOPHARMACOLOGY (2006)
Extending the evidence hierarchy to enhance evidence-based practice for substance use disorders
Jalie A. Tucker et al.
ADDICTION (2006)
Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up
E Krupitsky et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2002)